Literature DB >> 7928448

Nonrandom T-cell receptor J beta usage pattern in human CD4+ and CD8+ peripheral T cells.

M Jeddi-Tehrani1, J Grunewald, V Hodara, R Andersson, H Wigzell.   

Abstract

Association frequencies of TCR J beta gene segments with six V beta families (V beta 3, 6.1-3, 8, 9, 12, and 18) were analyzed in T-cell populations obtained from healthy blood donors. The six selected V beta families are located at various chromosomal positions relative to other recombinatorial elements (D beta, J beta, C beta). We report here that in CD4+ as well as CD8+ T-cell subsets, all 13 J beta gene segments were used in combination with all the V beta s tested and that no correlation between the genomic position of the individual V beta s and J beta gene segment usage was observed. J beta gene segment usage was found to be nonrandom in general, with J beta 2.7 and J beta 2.4 exhibiting highest and lowest frequency of utilization, respectively. J beta family 2 was used more frequently than J beta family 1 by the two T-cell subsets. Some individual J beta gene segments were skewed toward either CD4+ or CD8+ T cells. Thus, J beta 1.3 and J beta 1.6 were consistently biased toward expression in CD4+ T cells. In contrast, when combined with V beta 8 or V beta 9, J beta 2.1 results were skewed dramatically toward expression in CD8+ T cells. We also found 70 cases of expanded individual V beta/J beta associations in a total of 1092 investigated combinations, 62 of which were confined to the CD8+ T-cell populations. CD8+ T-cell populations are thus much more likely to contain TCR V beta/J beta-restricted expansions than CD4+ T cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7928448     DOI: 10.1016/0198-8859(94)90053-1

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  5 in total

1.  The T cell receptor repertoire of CD8+CD28- T lymphocytes is dominated by expanded clones that persist over time.

Authors:  E N Mugnaini; T Egeland; A Spurkland; J E Brinchmann
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

Review 2.  T cell receptor usage in malignant diseases.

Authors:  E Halapi; M Jeddi-Tehrani; A Osterborg; H Mellstedt
Journal:  Springer Semin Immunopathol       Date:  1999

3.  Overexpression of select T cell receptor V beta gene families within CD4+ and CD8+ T cell subsets of myasthenia gravis patients: a role for superantigen(s)?

Authors:  D Gigliotti; A K Lefvert; M Jeddi-Tehrani; S Esin; V Hodara; R Pirskanen; H Wigzell; R Andersson
Journal:  Mol Med       Date:  1996-07       Impact factor: 6.354

4.  Genetic control of T cell receptor BJ gene expression in peripheral lymphocytes of normal and rheumatoid arthritis monozygotic twins.

Authors:  T Nanki; H Kohsaka; N Mizushima; W E Ollier; D A Carson; N Miyasaka
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

5.  Somatic Variation of T-Cell Receptor Genes Strongly Associate with HLA Class Restriction.

Authors:  Paul L Klarenbeek; Marieke E Doorenspleet; Rebecca E E Esveldt; Barbera D C van Schaik; Neubury Lardy; Antoine H C van Kampen; Paul P Tak; Robert M Plenge; Frank Baas; Paul I W de Bakker; Niek de Vries
Journal:  PLoS One       Date:  2015-10-30       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.